Amitriptyline hydrochloride prices moved higher in all three major tracked regions in the third quarter of 2026, according to the latest Amitriptyline Hydrochloride Price Index from ChemAnalyst. Rising production costs in China, persistent producer-price inflation in the United States and higher manufacturing costs in Germany pushed the pharmaceutical-grade active ingredient upward, marking the first quarter since Q1 2026 in which all three regions rose together.
The move was most notable in China, where the index rebounded after a decline in Q2 2026, driven by surging production costs and elevated feedstock prices. In the United States, the index extended a run of gains that has now lasted four consecutive quarters, while Germany recorded its third straight quarterly increase.
Q3 2026 Amitriptyline Hydrochloride Price Snapshot
Region | Q3 2026 Index Direction | Main Driver |
|---|---|---|
Asia-Pacific (China) | Up | Surging production costs and high feedstock prices |
North America (USA) | Up | Producer prices up 6.3% and consumer inflation at 3.7% in September |
Europe (Germany) | Up | Producer prices up 4.6% in August and inflation at 3.3% in September |
A Year of Cost-Driven Volatility
Amitriptyline hydrochloride prices have tracked shifts in energy, petrochemical feedstocks and broader producer-price inflation over the past year.
In Q4 2025, overcapacity in China and a 1.9% decline in Chinese producer prices pushed the APAC index lower, while German producer prices fell 2.5%. In the United States, however, a 3.0% rise in producer prices and elevated natural gas costs lifted prices.
In Q1 2026, all three regions moved higher. Benzene and phthalic anhydride costs spiked in the US, Brent crude surged in March, and Middle East shipping disruptions affected feedstock flows. In Europe, energy costs rose sharply as natural gas spot prices climbed.
In Q2 2026, the markets diverged again. Easing benzene and toluene prices and weaker domestic demand pulled the Chinese index lower. In the US, producer prices rose 6.5% in May, while German producer prices increased 2.2%, with high energy costs and tight intermediate supply supporting prices.
Asia-Pacific: Production Costs Drive a Rebound
In Q3 2026, Chinese producers faced a sharp increase in production costs, while feedstock prices remained high. These pressures reversed the decline seen in Q2 and lifted the regional index. ChemAnalyst expects continued upward pressure in APAC as producers face high raw-material purchase costs.
North America: Inflation Keeps Prices Climbing
In the United States, broad cost inflation continued to support amitriptyline hydrochloride prices. Producer prices were up 6.3% and consumer inflation reached 3.7% in September 2026, raising costs across chemical inputs, energy, labour and logistics. The US index has now risen in every quarter since Q4 2025.
Europe: German Costs Continue to Rise
In Germany, producer prices rose 4.6% in August 2026, and inflation reached 3.3% in September. Higher costs for energy and chemical intermediates continued to feed through to pharmaceutical ingredient pricing, extending a run of increases that began in Q1 2026.
Feedstocks and Cost Drivers
As a synthetic pharmaceutical ingredient, amitriptyline hydrochloride is exposed to movements in petrochemical feedstocks and energy. ChemAnalyst's analysis links its cost base to benzene, toluene, phthalic anhydride, mixed xylenes, natural gas and crude oil. Changes in these inputs, together with producer-price inflation, energy tariffs and shipping disruptions, shape regional price trends.
Product and End-Use Demand
Amitriptyline hydrochloride is the hydrochloride salt of amitriptyline, a tricyclic antidepressant that works by inhibiting the reuptake of norepinephrine and serotonin in the central nervous system. It is used in medicines for depressive illness and for anxiety associated with depression. ChemAnalyst tracks the pharma-grade material, typically traded in 25 kg bags.
Companies tracked in the market include Accord Healthcare Inc., Viatris Inc., Sandoz Inc. and Vintage Pharmaceuticals Inc.
Amitriptyline Hydrochloride Price Outlook
With production costs elevated in China and producer-price inflation still running high in the US and Germany, cost pressures remain firmly in place. ChemAnalyst points to continued upward pressure in Asia-Pacific, driven by high raw-material purchase costs. Market participants will be watching feedstock prices, energy costs and inflation trends heading into 2027.
Why Amitriptyline Hydrochloride Price Tracking Matters
For pharmaceutical manufacturers, formulators and API buyers, regional cost trends can shift quickly, and regions do not always move together, as Q2 2026 showed. Reliable, regularly updated price data helps procurement teams time purchases, benchmark supplier quotes and manage budget risk.
ChemAnalyst's amitriptyline hydrochloride pricing page brings together the price index, historical price charts, regional market news, analysis and forecasts in one place.
Track the latest amitriptyline hydrochloride price trend, chart and forecast here: https://www.chemanalyst.com/Pricing-data/amitriptyline-hydrochloride-1496
About ChemAnalyst
ChemAnalyst is a market intelligence platform that provides price data, market news and analysis for chemicals, petrochemicals and pharmaceutical ingredients worldwide, helping buyers, suppliers and analysts make better-informed decisions.
Comments